Max F. Madu
The Netherlands Cancer Institute(NL)
Publications by Year
Research Areas
Cutaneous Melanoma Detection and Management, Melanoma and MAPK Pathways, Nonmelanoma Skin Cancer Studies, CAR-T cell therapy research, Immunotherapy and Immune Responses
Most-Cited Works
- → Reversal of pre-existing NGFR-driven tumor and immune therapy resistance(2020)116 cited
- → Sentinel node biopsy in melanoma: Current controversies addressed(2016)63 cited
- → Isolated Limb Perfusion for Melanoma is Safe and Effective in Elderly Patients(2017)34 cited
- → External validation of the American Joint Committee on Cancer 8th edition melanoma staging system: who needs adjuvant treatment?(2019)28 cited
- → Immediate completion lymph node dissection in stage IIIA melanoma does not provide significant additional staging information beyond EORTC SN tumour burden criteria(2017)23 cited
- → PET/CT surveillance detects asymptomatic recurrences in stage IIIB and IIIC melanoma patients: a prospective cohort study(2017)19 cited
- → Blue dye can be safely omitted in most sentinel node procedures for melanoma(2016)18 cited
- → Efficacy of isolated limb perfusion (ILP) in patients with Merkel cell carcinoma (MCC): A multicenter experience(2017)17 cited
- → Optimal extent of completion lymphadenectomy for patients with melanoma and a positive sentinel node in the groin(2017)15 cited
- → Clinical prognostic markers in stage IIIC melanoma(2017)10 cited